Global Bio-implants Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

  • ID: 4516128
  • Report
  • Region: Global
  • 720 pages
  • Data Bridge Market Research Private Limited
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Biotronik Se & Co.Kg
  • C.R. Bard, Inc.
  • F. Hoffmann-La Roche AG
  • Medtronic
  • Mimedx Group, Inc.
  • MORE
Global bio-implants market is expected to reach USD 308,837.20 million by 2025 from USD 186,162.16 million in 2018, at a CAGR of 7.5% in the forecast period 2018 to 2025.

The major factors driving the growth of this market are rising number of aging and geriatric population, changing lifestyle problems, rising incidence of chronic diseases, increasing awareness about cosmetic implants, technological advancement in implants, rising demand for non-surgical bio-implants are the factors which is driving the growth of the market.

The key market players for Global Bio-Implants Market are listed below:
  • Abbott Laboratories
  • Medtronic
  • Boston Scientific Corporation
  • Bio-Rad Laboratories, Inc.
  • Somnomed Limited
  • Johnson & Johnson Services, Inc.
  • Edwards Lifesciences Corporation
  • F. Hoffmann-La Roche AG
  • C.R. Bard, Inc.
  • Mimedx Group, Inc.
  • Biotronik Se & Co.Kg
The market is further segmented into:
  • Product Type
  • Type
  • Material
  • Mode of Administration
  • End-user
The global bio-implants market is segmented based on product type into orthopedics & trauma, pacing devices, stents & related implants, spinal implants, ophthalmic implants, structural cardiac implants, dental implants, neurostimulators implants, prosthetic implants, and others. In 2018, orthopedics & trauma is expected to dominate the bio-implants market with 24.8% market share and is expected to reach USD 80,618.43 million by 2025, growing at the highest CAGR of 8.3% in the forecast period 2018 to 2025.

The global bio-implants market is segmented on the basis of type into allograft, autograft, xenograft, synthetic, and others. In 2018, allograft is expected to dominate the bio-implants market with 42.8% market share and is expected to reach USD 135,491.48 million by 2025, growing at the highest CAGR of 7.9% in the forecast period 2018 to 2025.

The global bio-implants market is segmented on the basis of material into biomaterial metal, alloy, polymers, ceramics, and acrylic hydrogel. In 2018, biomaterial metal is expected to dominate the bio-implants market with 31.4% market share and is expected to reach USD 97,392.26 million by 2025, growing at a CAGR of 7.6% in the forecast period 2018 to 2025.

The global bio-implants market is segmented on the basis of mode of administration into surgical and non-surgical. In 2018, surgical is expected to dominate the bio-implants market with 60.6% market share and is expected to reach USD 183,310.49 million by 2025, growing at a CAGR of 7.2% in the forecast period 2018 to 2025.

The global bio-implants market is segmented on the basis of end users into hospitals, ambulatory surgical centers, clinics, and others. In 2018, hospitals is expected to dominate the bio-implants market with 46.0% market share and is expected to reach USD 144,320.98 million by 2025, growing at the highest CAGR of 7.7% in the forecast period 2018 to 2025.

Based on geography, the Global bio-implants market is segmented into geographical regions, such as:
  • North- America,
  • South America
  • Global
  • Asia-Pacific
  • Middle East and Africa
Covered in this report

The report covers the present scenario and the growth prospects of the global bio-implants market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst’s time when you purchase this market report.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Biotronik Se & Co.Kg
  • C.R. Bard, Inc.
  • F. Hoffmann-La Roche AG
  • Medtronic
  • Mimedx Group, Inc.
  • MORE
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Overview of Global Bio-Implants Market
1.4. Currency and Pricing
1.5. Limitation
1.6. Markets Covered

2. Market Segmentation
2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered For the Study
2.4. Currency and Pricing
2.5. Research Methodology
2.6. Primary Interviews With Key Opinion Leaders
2.7. Secondary Sources
2.8. Assumptions

3. Market Overview
3.1. Drivers
3.1.1. Rising Number of Aging and Geriatric Population
3.1.2. Changing Lifestyle Problems
3.1.3. Rising Incidence of Chronic Diseases
3.1.4. Increasing Awareness About Cosmetic Implants
3.1.5. Technological Advancement in Implants
3.1.6. Rising Demand For Non-Surgical Bio-Implants
3.2. Restraints
3.2.1. High Cost of Implants
3.2.2. Regulatory Scenario
3.2.3. Unfavourable Reimbursement Policies
3.3. Opportunities
3.3.1. Emerging Inclination For Mis Surgeries
3.3.2. Growing Number of Diagnostic Centers and Clinics
3.3.3. Emerging Countries
3.3.4. Rising Medical Tourism
3.4. Challenges
3.4.1. Side-Effects of Various Cosmetic Surgery
3.4.2. Lack of Trained Professionals

4. Executive Summary

5. Premium Insights

6. Global Bio-Implants Market, By Product Type
6.1. Overview
6.2. Orthopedics & Trauma
6.2.1. Reconstructive Joint Replacements
6.2.1.1. Knee Replacement Implants
6.2.1.2. Hip Replacement Implants
6.2.1.3. Extremities
6.2.2. Orthobiologics
6.2.2.1. Hyaluronic Acid
6.2.2.2. Bone Substitutes
6.2.2.3. Bone Growth Factors
6.2.2.4. Tissue Implants
6.2.2.5. Bone Cement
6.2.3. Trauma Implants
6.2.3.1. Internal Trauma Fixation Devices
6.2.3.2. Craniomaxillofacial Fixation Devices
6.2.3.3. Implantable Trauma Stimulators
6.2.4. Sports Medicine
6.3. Pacing Devices
6.3.1. Cardiac Resynchronization Therapy Devices (Crtd)
6.3.2. Implantable Cardioverter Defibrillators (Icd)
6.3.3. Implantable Cardiac Pacemakers (Icp)
6.3.3.1. Single Chambered
6.3.3.2. Dual Chambered
6.3.3.3. Multiple Chambered
6.3.4. Pacing Accessories
6.3.4.1. Pacing Leads
6.3.4.2. Pacing Batteries
6.4. Stents & Related Implants
6.4.1. Coronary Stents
6.4.1.1. Drug-Eluting Stents
6.4.1.2. Bare-Metal Coronary Stents
6.4.1.3. Bioabsorbable Stents
6.4.2. Peripheral Stents
6.4.2.1. Endovascular Stent-Grafts
6.4.2.2. Renal & Related Stents
6.4.2.3. Femoral & Related Stents
6.4.2.4. Carotid Stents
6.4.3. Stent-Related Implants
6.4.3.1. Synthetic Grafts
6.4.3.2. Vascular Grafts
6.4.3.3. Peripheral Grafts
6.4.3.4. Vena Cava Filters
6.5. Spinal Implants
6.5.1. Thoracolumbar Implants
6.5.2. Intervertebral Spacers
6.5.3. Machined Allograft Spacers
6.5.4. Cervical Implants
6.5.5. Motion Preservation Implants
6.5.6. Implantable Spinal Stimulators
6.6. Ophthalmic Implants
6.6.1. Intraocular Lens
6.6.2. Glaucoma & Other Lenses
6.7. Structural Cardiac Implants
6.7.1. Heart Valves & Accessories
6.7.2. Tissue Heart Valves
6.7.3. Mechanical Heart Valves
6.7.4. Heart Valve Repair Devices
6.7.5. Ventricular Assist Device (Vad)
6.7.6. Implantable Heart Monitors
6.7.7. Insertable Loop Recorders (Ilrs)
6.7.8. Implantable Hemodynamic Monitors (Ihm)
6.8. Dental Implants
6.8.1. Plate Form Dental Implants
6.8.2. Root Form Dental Implants
6.9. Neurostimulators Implants
6.9.1. Cortical Stimulators
6.9.2. Deep Brain Stimulators
6.9.3. Sacral Nerve Stimulators
6.9.4. Spinal Cord Stimulators
6.9.5. Vagus Nerve Stimulators
6.10. Prosthetic Implants
6.10.1. Osseointegration
6.10.2. Titanium-Based Prosthetic Implants
6.11. Others
6.11.1. Gynecological Devices
6.11.2. Drug Implants
6.11.3. Cosmetic Implants
6.11.4. Gastroenterological Implants
6.11.5. Urological Implants
6.11.6. Skin & Wound Care
6.11.7. Otolaryngeal Implants

7. Global Bio-Implants Market, By Type
7.1. Overview
7.2. Allograft
7.3. Autograft
7.4. Xenograft
7.5. Synthetic
7.6. Others

8. Global Bio-Implants Market, By Material
8.1. Overview
8.2. Biomaterial Metal
8.2.1. Titanium
8.2.2. Gold
8.2.3. Silver
8.2.4. Platinum
8.3. Alloy
8.4. Polymer
8.4.1. Natural Polymers
8.4.2. Synthetic Polymers
8.5. Ceramics
8.6. Acrylic Hydrogel

9. Global Bio-Implants Market, Mode of Administration
9.1. Overview
9.2. Surgical
9.3. Non-Surgical
9.3.1. Injectable Fillers/Biomaterials
9.3.2. Osteogenic Injectable Bone Substitutes
9.3.3. Viscosupplementation
9.3.4. Viscoaugmentation

10. Global Bio-Implants Market, By End-User
10.1. Overview
10.2. Clinics
10.3. Hospitals
10.4. Ambulatory Surgical Centers
10.5. Others

11. Global Bio-Implants Market, By Geography
11.1. Overview
11.2. North America
11.2.1. U.S.
11.2.2. Canada
11.2.3. Mexico
11.3. Europe
11.3.1. Germany
11.3.2. France
11.3.3. U.K.
11.3.4. Italy
11.3.5. Spain
11.3.6. Switzerland
11.3.7. Netherlands
11.3.8. Belgium
11.3.9. Russia
11.3.10. Turkey
11.3.11. Rest of Europe
11.4. Asia-Pacific
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. South Korea
11.4.5. Australia
11.4.6. Singapore
11.4.7. Thailand
11.4.8. Malaysia
11.4.9. Indonesia
11.4.10. Philippines
11.4.11. Rest of Asia-Pacific
11.5. South America
11.5.1. Brazil
11.5.2. Rest of South America
11.6. Middle East and Africa
11.6.1. South Africa
11.6.2. Rest of Middle East and Africa

12. Global Bio-Implants Market, Company Landscape
12.1. Company Share Analysis: Global
12.2. Company Share Analysis: North America
12.3. Company Share Analysis: Europe
12.4. Company Share Analysis: Asia Pacific

13. Company Profiles
13.1. Medtronic
13.1.1. Company Overview
13.1.2. Revenue Analysis
13.1.3. Product Portfolio
13.1.4. Recent Developments
13.2. Johnson & Johnson Services, Inc.
13.2.1. Company Overview
13.2.2. Johnson & Johnson Services, Inc.: Revenue Analysis
13.2.3. Product Portfolio
13.2.4. Recent Developments
13.3. Edward Lifesciences Corporation
13.3.1. Company Overview
13.3.2. Edward Lifesciences Corporation :Revenue Analysis
13.3.3. Product Portfolio
13.3.4. Recent Developments
13.4. Boston Scientific Corporation
13.4.1. Company Overview
13.4.2. Boston Scientific Corporation: Revenue Analysis
13.4.3. Product Portfolio
13.4.4. Recent Developments
13.5. Integra Lifesciences Corporation
13.5.1. Company Overview
13.5.2. Integra Lifesciences Corporation :Revenue Analysis
13.5.3. Product Portfolio
13.5.4. Recent Developments
13.6. Abbott
13.6.1. Company Overview
13.6.2. Abbott :Revenue Analysis
13.6.3. Product Portfolio
13.6.4. Recent Developments
13.7. C. R. Bard, Inc.
13.7.1. Company Overview
13.7.2. C. R. Bard, Inc.:Revenue Analysis
13.7.3. Product Portfolio
13.7.4. Recent Developments
13.8. Zimmer Biomet
13.8.1. Company Overview
13.8.2. Zimmer Biomet :Revenue Analysis
13.8.3. Product Portfolio
13.8.4. Recent Developments
13.9. Biotronik Se & Co. Kg
13.9.1. Company Overview
13.9.2. Biotronik Se & Co. Kg :Company Snapshot
13.9.3. Product Portfolio
13.9.4. Recent Developments
13.10. Lifenet Health, Inc.
13.10.1. Company Overview
13.10.2. Lifenet Health, Inc.:Company Snapshot
13.10.3. Product Portfolio
13.10.4. Recent Developments
13.11. Integrated Orbital Implants
13.11.1. Company Overview
13.11.2. Integrated Orbital Implants :Company Snapshot
13.11.3. Product Portfolio
13.11.4. Recent Developments
13.12. Smith & Nephew
13.12.1. Company Overview
13.12.2. Smith & Nephew :Revenue Analysis
13.12.3. Product Portfolio
13.12.4. Recent Developments
13.13. Stryker
13.13.1. Company Overview
13.13.2. Stryker :Revenue Analysis
13.13.3. Product Portfolio
13.13.4. Recent Developments
13.14. W. L. Gore & Associates, Inc
13.14.1. Company Overview
13.14.2. W. L. Gore & Associates, Inc :Company Snapshot
13.14.3. Product Portfolio
13.14.4. Recent Developments
13.15. Valeant Pharmaceuticals International Inc.
13.15.1. Company Overview
13.15.2. Valeant Pharmaceuticals International Inc.:Revenue Analysis
13.15.3. Product Portfolio
13.15.4. Recent Developments
13.16. Somnomed
13.16.1. Company Overview
13.16.2. Somnomed :Revenue Analysis
13.16.3. Product Portfolio
13.16.4. Recent Developments
13.17. Wright Medical Group N.V.
13.17.1. Company Overview
13.17.2. Wright Medical Group N.V.:Revenue Analysis
13.17.3. Product Portfolio
13.17.4. Recent Developments
13.18. Livanova Plc
13.18.1. Company Overview
13.18.2. Livanova Plc :Revenue Analysis
13.18.3. Product Portfolio
13.18.4. Recent Developments
13.19. St. Jude Medical, Inc. (A Subsidiary of Abbott)
13.19.1. Company Overview
13.19.2. St. Jude Medical, Inc.:Company Snapshot
13.19.3. Product Portfolio
13.19.4. Recent Developments
13.20. Mimedx Group, Inc.
13.20.1. Company Overview
13.20.2. Mimedx Group, Inc.:Revenue Analysis
13.20.3. Product Portfolio
13.20.4. Recent Developments
13.21. Cook Group
13.21.1. Company Overview
13.21.2. Cook Group :Company Snapshot
13.21.3. Product Portfolio
13.21.4. Recent Developments

14. Related Reports
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • Medtronic
  • Boston Scientific Corporation
  • Bio-Rad Laboratories, Inc.
  • Somnomed Limited
  • Johnson & Johnson Services, Inc.
  • Edwards Lifesciences Corporation
  • F. Hoffmann-La Roche AG
  • C.R. Bard, Inc.
  • Mimedx Group, Inc.
  • Biotronik Se & Co.Kg
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll